111 related articles for article (PubMed ID: 2678952)
1. Effect of SK&F 86002 on cytokine production by human monocytes.
Lee JC; Rebar L; Laydon JT
Agents Actions; 1989 Jun; 27(3-4):277-9. PubMed ID: 2678952
[TBL] [Abstract][Full Text] [Related]
2. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level.
Young P; McDonnell P; Dunnington D; Hand A; Laydon J; Lee J
Agents Actions; 1993; 39 Spec No():C67-9. PubMed ID: 8273589
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline.
Prabhakar U; Lipshutz D; Truneh A
Int J Immunopharmacol; 1993 Feb; 15(2):205-9. PubMed ID: 7682199
[TBL] [Abstract][Full Text] [Related]
4. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro.
Votta BJ; Bertolini DR
Bone; 1994; 15(5):533-8. PubMed ID: 7980964
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms.
Kassis S; Prabhakar U; Lee JC
Agents Actions; 1993; 39 Spec No():C64-6. PubMed ID: 7506004
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of SK&F 86002 on monocyte IL-1 production.
Lee JC; Votta B; Griswold DE; Hanna N
Agents Actions; 1989 Jun; 27(3-4):280-1. PubMed ID: 2801311
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.
Lee JC; Griswold DE; Votta B; Hanna N
Int J Immunopharmacol; 1988; 10(7):835-43. PubMed ID: 3148560
[TBL] [Abstract][Full Text] [Related]
8. Effects of pyridinyl imidazole compounds on murine TNF-alpha production.
Olivera DL; Laydon JT; Hillegass L; Badger AM; Lee JC
Agents Actions; 1993; 39 Spec No():C55-7. PubMed ID: 8273586
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes.
Lepe-Zuniga JL; Klostergaard J
Lymphokine Res; 1990; 9(3):309-19. PubMed ID: 2204768
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
Perregaux DG; Dean D; Cronan M; Connelly P; Gabel CA
Mol Pharmacol; 1995 Sep; 48(3):433-42. PubMed ID: 7565623
[TBL] [Abstract][Full Text] [Related]
11. Effects of SK&F 86002 on cytokine-stimulated IL6 production in cultured neonatal mouse calvaria and SaOS2 osteoblastic cells: the role of prostaglandins and other mechanisms of action.
Blanque R; Cottereaux C; Gardner CR
Drugs Exp Clin Res; 1997; 23(2):63-70. PubMed ID: 9309381
[TBL] [Abstract][Full Text] [Related]
12. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
13. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
Danis VA; Franic GM; Rathjen DA; Brooks PM
Clin Exp Immunol; 1991 Jul; 85(1):143-50. PubMed ID: 1906383
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products.
Chin J; Kostura MJ
J Immunol; 1993 Nov; 151(10):5574-85. PubMed ID: 8228247
[TBL] [Abstract][Full Text] [Related]
15. SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.
Triplett EA; Kruse-Elliott KT; Hart AP; Schram BR; MacWilliams PS; Cooley AJ; Clayton MK; Darien BJ
Shock; 1996 Nov; 6(5):357-64. PubMed ID: 8946652
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock.
Olivera DL; Esser KM; Lee JC; Greig RG; Badger AM
Circ Shock; 1992 Aug; 37(4):301-6. PubMed ID: 1446388
[TBL] [Abstract][Full Text] [Related]
17. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1).
Molina JM; Schindler R; Ferriani R; Sakaguchi M; Vannier E; Dinarello CA; Groopman JE
J Infect Dis; 1990 May; 161(5):888-93. PubMed ID: 2182729
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
[TBL] [Abstract][Full Text] [Related]
19. Reduced endotoxin-induced production of tumor necrosis factor activity by equine peritoneal macrophages exposed to the dual inhibitor of arachidonic acid metabolism, SK & F 86002.
Morris DD; Crowe N; Moore JN
Can J Vet Res; 1992 Apr; 56(2):110-4. PubMed ID: 1591653
[TBL] [Abstract][Full Text] [Related]
20. Regulation of interferon production by human monocytes: requirements for priming for lipopolysaccharide-induced production.
Hayes MP; Enterline JC; Gerrard TL; Zoon KC
J Leukoc Biol; 1991 Aug; 50(2):176-81. PubMed ID: 1649241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
